ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.891,68
-0,53%
S&P 500
5.667,56
0,08%
Dow Jones
41.985,35
0,08%
Euro vs US Dollar
1,08745
-0,01%
Bitcoin
84.257,75
0,25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Passage Bio Inc (PASG)

  7. Passage Bio Inc (PASG) News

PASG

Passage Bio (PASG)

Passage Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PASG
DatumZeitQuelleÜberschriftSymbolFirma
18/03/202522h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
18/03/202522h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
18/03/202522h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
05/03/202512h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PASGPassage Bio Inc
05/03/202512h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PASGPassage Bio Inc
04/03/202513h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PASGPassage Bio Inc
04/03/202513h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
04/03/202513h00GlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
26/02/202513h00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
14/02/202515h01Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PASGPassage Bio Inc
12/02/202522h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
31/01/202522h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
10/01/202513h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
10/01/202513h00GlobeNewswire Inc.Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business UpdatesNASDAQ:PASGPassage Bio Inc
14/11/202423h21Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PASGPassage Bio Inc
14/11/202423h01Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PASGPassage Bio Inc
14/11/202418h03Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PASGPassage Bio Inc
13/11/202413h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
13/11/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
13/11/202413h00GlobeNewswire Inc.Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
06/11/202413h00GlobeNewswire Inc.Passage Bio to Present at Guggenheim Securities Healthcare Innovation ConferenceNASDAQ:PASGPassage Bio Inc
24/10/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
24/10/202413h00GlobeNewswire Inc.Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual ConferenceNASDAQ:PASGPassage Bio Inc
02/10/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
23/09/202413h00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines ConferenceNASDAQ:PASGPassage Bio Inc
16/09/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
16/09/202413h00GlobeNewswire Inc.Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)NASDAQ:PASGPassage Bio Inc
10/09/202413h52GlobeNewswire Inc.Passage Bio Welcomes Tom Kassberg to Board of DirectorsNASDAQ:PASGPassage Bio Inc
10/09/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
06/09/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PASG

Kürzlich von Ihnen besucht

NASDAQI
FDIF
Fidelity Disruptors ETF
AMEX
VGK
Vanguard FTSE Europe
EU
CACT
CAC All Tradeable
NYSE
QXM
COIN
GOALUSD
Goal Bonanza
COIN
APEDUSD
Aped
EU
XIOR
Xior Student Housing NV
TSXV
BTV
BlueRush
EU
REAL
Realco NV
AMEX
RGI
Invesco S&P 500 Equal We...
BIT
WCOE
ETF
COIN
EGCCUSD
Engine Token
EU
BELS
Bel Small
LSE
0OHB
Yuri Gagarin Ad
COIN
MITHUSD
Mithril
DBI
I1PW
XEGB1UE1CCHFINAV
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten